Willard Applefeld, MD
Critical Care Medicine · Baltimore, MDNPI 1992190045
Payments from drug & device makers
What this record shows
Abbott accounts for 81.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,123, 2.1 times the $1,026 reported in 2023.
Across 31 payments — averaging $115.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$178
- United Therapeutics Corporation$165
- Abiomed$131
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$95
- Angiodynamics, Inc.$58
- plus $39 from 1 others
What the payments were for
- Travel & lodging$2,13960%
- Food & beverage$1,43540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 21 | $2,908 |
| Medtronic | 2 | $178 |
| United Therapeutics Corporation | 3 | $165 |
| Abiomed | 1 | $131 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $95 |
| Angiodynamics, Inc. | 2 | $58 |
| Johnson & Johnson | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,574 in reported general payments places this provider in the 85th percentile of 231 critical care medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 14 | $9,868 |
| Ezetimibe | 20 | $466 |
| Rosuvastatin Calcium | 11 | $222 |
| Spironolactone | 16 | $136 |
| Carvedilol | 12 | $91 |
| Atorvastatin Calcium | 12 | $52 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Baltimore
- David Feller KopmanBaltimore$236K
- Elizabeth HuntBaltimore$182K
- Edward BrittBaltimore$70K
- Nirav ShahBaltimore$55K
- Steven KellerBaltimore$31K
- Nader HabashiBaltimore$25K
- van HoldenBaltimore$21K
- Renee DixonBaltimore$10K
- Wendy ZiaiBaltimore$8K
- Andrea LevineBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.